Comments

Novo Nordisk

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

NVONYSE

Novo Nordisk (NVO) Forecast

News Earnings Novo Nordisk (NVO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Novo Nordisk (NYSE:NVO) Stock Quotes, Forecast and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open	$110.78
Close	-
Volume / Avg.	1.77M / 4.85M
Day Range	$109.96 - $110.88
52 Wk Range	94.73 - 148.15
Market Cap	$489.87B
P/E Ratio	36.26
Dividend Yield	1.33%
Exchange	NYSE
RSI	54
Short Interest	0.16%
Days to Cover	1

Recent News

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a $100B market.

Surbhi Jain

Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum

Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the booming weight loss market with tactical trading opportunities.

Vandana Singh

Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$110.78
Close	-
Volume / Avg.	1.77M / 4.85M
Day Range	$109.96 - $110.88
52 Wk Range	94.73 - 148.15
Market Cap	$489.87B
P/E Ratio	36.26
Dividend Yield	1.33%
Exchange	NYSE
RSI	54
Short Interest	0.16%
Days to Cover	1

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

Novo Nordisk has a consensus price target of $123.86.

What is the current price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $110.27 last updated December 3, 2024 at 11:58 AM EST.

Does Novo Nordisk (NVO) pay a dividend?

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q4 earnings are confirmed for Wednesday, January 29, 2025.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.